UNSPSC 51285403: Cefivitril

This classification denotes a cephalosporin antibiotic with the molecular formula C15H15N7O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 776E09GMHQ, chemically known as (6r,7r)-7-(2-(((z)-2-cyanovinyl)thio)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. but more generally known as cefivitril, which bears US NIH Compound Identifier 6443795.

UNSPSC 51285403 Cefivitril is a Commodity code that captures pharmaceutical products, though recent state and local procurement activity under this code shows little direct alignment with the code's nominal scope. The two most recent opportunities posted under this code involve naloxone and safe drug deactivation systems (Seminole County, Florida), and a completed piggyback pharmaceutical warehouse award for antibiotic tablets (Illinois Department of Public Health), neither of which are cefivitril or closely related medications. State and local procurement offices appear to use this code inconsistently or as a catch-all for pharmaceutical procurement that does not fit narrower categories. Issuing bodies soliciting under the code include state health departments and county health authorities pursuing community health and emergency response pharmaceutical supplies.

Activity under UNSPSC 51285403 is geographically dispersed but sparse. Recent opportunities include Illinois (a completed $2,999,999.11 three-year pharmaceutical warehouse award to Chartwell Rx LLC through the MMCAP Infuse cooperative purchasing vehicle, notice issued August 28, 2026) and Florida (Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, posted June 30, 2026, with response due July 26, 2026). The code shows limited recent solicitation volume, and the mismatch between the code's name and the products actually being bought suggests that state and local procurement offices may be applying this code inconsistently to pharmaceutical categories outside its intended scope. Business development professionals pursuing state and local opportunities in pharmaceutical supply should monitor cooperative purchasing vehicles such as MMCAP Infuse and track county health department procurement channels, though this particular code does not appear to be generating consistent or predictable opportunity flow.